MYC and BCL2 mRNA Expression As Determined By NGS Predicts Survival in DLBCL in GCB but Not in ABC Subgroup
Maher Albitar(Center for Genomic Science), Ken H. Young(Duke Medical Center), Karen Dybkær(Aalborg University Hospital), Govind Bhagat(Columbia University Irving Medical Center), Ivan De Dios(Georgia Southern University), Maurilio Ponzoni(San Raffaele University of Rome), Eric D. Hsi(Mayo Clinic), Xu‐Monette Y Zijun(The University of Texas MD Anderson Cancer Center), J. Han van Krieken(Radboud University Nijmegen), Alexandar Tzankov(University of Basel), Carlo Visco(University of Verona), Youli Zu(Methodist Hospital), Wayne Tam(Cornell University), Yingjun Wang(South China University of Technology), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Deng Manman(The University of Texas MD Anderson Cancer Center), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center), Yong Li(Baylor College of Medicine), Jane N. Winter(Northwestern University), Andrés JM Ferreri, Michael Møller(Hospital South West Jutland)
Cited by 1
Related Papers
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
|Nature|2011|1.5k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k